OPINIONBuffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015By Emily StewartDec 15, 2014 9:27 AM EST
OPINIONHealth Care Stocks: A Year in Review and Predictions for 2015By Richard SaintvilusDec 10, 2014 11:38 AM EST
MARKETSAchillion Pharmaceuticals (ACHN) Stock Falls After Two Days of GainsBy Andrew MeolaJun 11, 2014 10:20 AM EDT
MARKETSWhy Achillion Pharmaceuticals (ACHN) Stock Is Surging Today (Update)By Andrew MeolaJun 10, 2014 4:20 PM EDT
INVESTINGThis Biotech Stock Could Be the Next Big Short SqueezeBy Roberto PedoneJun 10, 2014 2:38 PM EDT
JIM CRAMER'Fast Money' Recap: Markets Start Another Week on Positive NoteBy Bret KenwellJun 10, 2014 5:00 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: What Was Jim Cramer Thinking?By Scott RuttJun 9, 2014 8:13 PM EDT
MARKETSNo News Is OK News as Markets Hold Onto Record GainsBy Keris Alison LahiffJun 9, 2014 4:13 PM EDT
MARKETSWhy Achillion Pharmaceuticals (ACHN) Stock Is Up Today (Update)By Andrew MeolaJun 9, 2014 4:10 PM EDT
MARKETSWhy Idenix Pharmaceuticals (IDIX) Exploded to a One-Year High Today (Update)By Andrew MeolaJun 9, 2014 4:05 PM EDT
MARKETSJim Cramer Talks Dendreon (DNDN), Salesforce.com (CRM) and Yelp (YELP)By Andrew MeolaJun 9, 2014 12:18 PM EDT
MERGERS AND ACQUISITIONSMerck Adds HCV Candidates with Idenix BuyBy Pamela TaulbeeJun 9, 2014 11:50 AM EDT
INVESTINGAchillion Pharma Might be Next Hep C Takeout TargetBy Adam FeuersteinJun 9, 2014 9:22 AM EDT
INVESTINGMerck Buys Idenix for $3.9B in Yet Another Blockbuster Hep C DealBy Adam FeuersteinJun 9, 2014 8:27 AM EDT
